Avid Bioservices Inc (CDMO)

[jakedogman1]

i guess the web page update is consistent with company update

"The company will pursue a clinical development strategy focused on conducting small, early stage studies of bavituximab in combination with I-O agents. These trials may be conducted as part of ongoing collaborations with AstraZeneca and the National Comprehensive Cancer Network (NCCN). The goal of these trials will be to generate compelling data capable of driving partnering interest. As part of this new strategy, the company has discontinued plans to initiate further Phase II and Phase III trials."


So did the info out of asco change the plan or did the data.... or the capability of pphm to run the trial....

on another note: another potential bp

Planned studies include bavituximab in combination with xxxxxxxxxxxx in xxxxxxx xxxxxxx,

it's out there... just have to find it